BVDU Medical College, Pune (IR-17-MEDI )

Size: px
Start display at page:

Download "BVDU Medical College, Pune (IR-17-MEDI )"

Transcription

1 Parameter 2D.FPPP Sr. No Financial Year Name of Faculty (Principal Investigator) Medical College, Pune (IR-17-MEDI ) Name of the Funding agency Title of the Project Sanct ioned order no. Sanct ioned date Amount Received (In Rupees) Amount received (in words) Dr Lalwani John opking Bloomberg School of Public ealth BASIS Study :- Baseline Assessment of streptococcus Pneumoniae In India Serotypes Five lakh eighty five Dr J S Gothankar Bill Milinda Gates Foundation Pueumonia research initiative in Urban slums and rural areas of Maharashtra lakh Dr. Jitendra Oswal Serum Institute of India Ltd Jet MMR vaccine study: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study Comparing Safety And Immunogenicity Of Measles- Mumps-Rubella (MMR) subcutaneous vaccination by Disposable-Syringe Jet Injector To Vaccination Needle And Syringe For The Administration In ealthy Infants In Indian Aged To 18 Months Six lakh Sixtyseven eight

2 Dr. Sonali Palkar Dr. Nandini Malshe Shanta biotech ltd Serum Institute of India Ltd Dr. S K Lalwani Biological -E Shantha- Rota vaccine study: A phase III study to evaluate immune non inferiority and safety of the all in one liquid formulation of a live attenuated tetravalent (G1-G4) Bovine-uman Reassortant Rotavirus Vaccine (BRV-TV) to a licensed vaccine RotaTeq when administered as three dose series to Indian Infants concomitantly with other routinely recommended vaccines for the age. Jet Pentavac vaccine study: A Phase IV, non-inferiority, observer blind, randomized clinical study comparing safety and immunogenicity of DTP-B- IB vaccination by disposablesyringe jet injector to vaccination by needle and Syringe in ealthy infants in India. BE - JE vaccine study: A Multicentric open label noninterventional post marketing Surveillance study to evaluate safety and tolerability of BE s inactivated vero cell derived Japanese Encephalitis vaccine in 1 to 3 year old healthy children in a two dose schedule Eleven lakh Thirty Nine sixty Six lakh Seventy six Seven Two lakh Ninety four Five

3 Dr. Neeta anumante Dr. Sonali Palkar Dr. Sanjay Lalwani Cadila ealthcare Ltd Shanta biotech ltd uman Biological Institute Cadila Measles Phase III - A prospective, randomized, single blind, parallel, active controlled, multicentre, non-inferiority, phase III clinical study to evaluate the immunogenicity and safety of single-dose and multi-dose vials of Measles vaccine (Live) (Freezedried) of M/s Cadila ealthcare Limited compared to Measles vaccine (Live) (Freeze-dried) of M/s Serum Institute of India Limited in healthy paediatric subjects aged 9-12 months Rota Surveillance study: A Multicenter prospective community-based surveillance to estimate the burden of rotavirus gastroenteritis in children 24 months of age in India. uman Biological Pentavalent Vaccine- A Phase I/II (Pilot) Trial to Evaluate the Safety and Immunogenicity of BI Pentavalent (DTwP-b-ib [Liquid]) Combination Vaccine in Two Groups of ealthy Subjects from 16 Months to 24 Months of Age and Two Years to Five Years of Age Two lakh Fifty eight Two twenty three Seven lakh Twenty one two One lakh sixty nine thusand five

4 Dr. S K Lalwani Serum Institute of India Ltd Dr Priti Dhande BVU, Pune Shaikh Sabina ICMR ManasiDeshmukh ICMR Mahima Arya ICMR Easy Four TT vaccine study: An Open Label, Randomized, Multicenter study to Evaluate and Compare the Immunogenicity and Reactogenicity of DTwP-ib vaccine (Easyfour-TT, Panacea Biotec Ltd.) with Quadrovax (Tetravalent DTwP/ib Vaccine, Serum Institute of India Ltd.) in ealthy Infants Topical Pterocarpus Santalinus in Freund s adjuvant induced rheumatoid arthritis in albino rats Infection control measures and practices among healthcare workers in TB hospital Prevalence of Aflatoxin Contamination in Groundnut in Pune City Negating Wonder Drugs: Knowledge, Attitudes And Behaviour Regarding Antibiotics Use And Misuse Among Adults- A cross sectional survey 4- / One lakh twenty eight eight ninety Thirty

5 20-16 Nikita Utpat ICMR Tanvi Bafna ICMR Akshata Bansude ICMR Radhika Sudhir ICMR Radhika Deshpande ICMR Jitesh Satija ICMR Dr. Kharche J. S. BVU, Pune Effectiveness of SMART ealth Education Model On Knowledge And Attitudes Of School Students In Rural Area About Swachh Bharat Abhiyan And Sanitation Practices Quality of Life of Parents of Children Suffering From aematological Diseases and Pediatric Malignancies Comparing the effect of cow ghee and butter on memory and lipid profile of wistar rats Staphylococcus aureus and Pseudomonas aeruginosa to Blue LightIrradiation for Possible Role in Antimicrobial Therapy A study of the depth of the angle of the anterior chamber and its correlation with refractive status and intraocular pressure in a sample Indian population A clinical study of vision in female relatives of males with defective color perception Evaluation of risk factors for type II diabetes malletus and hypertension in Pune urban population 25000

6 4- / Dr. A. Pranita BVU, Pune Dr. Gayatri Godbole Dr. Madhuwanti Karandikar BVU, Pune BVU, Pune Insulin resistance and obesity status in post-menopausal women Corelation of dementia and levels of Vitamin D3 in elderly population Effect of Protein rich supplimentaion on reproductive function of multigeneraltionaly undernourished wistar rats 4- /5 4- /5 4- / Fifty Thirty Fourty

7 Dr. Jayashree Dawane Dr. Vrushali Thakar Dr. Lalwani Dr. Lalwani BVU, Pune BVU, Pune Cadila ealthcare Ltd Cadila ealthcare Ltd Evaluation of prophylactic effect of herbal formulation in streptozotocin in FF diet induced diabetic rat model Vancomycin resistance among methicillin resistant staphylococcus aureus isolates from tertiary care hospital Cadila Measles- A randomized, open label, multicentric, phase II clinical trial to assess the immunogenicity and safety of Measles vaccine (Live) (Freezedried) of M/s Cadila ealthcare Ltd. in healthy pediatric subjects aged 9-12 months Cadila MMR- A randomized, open label, multicentric, phase II clinical trial to assess the immunogenicity and safety of Measles, Mums and rubella 4- /5 4- / Fourty Fourty Two lakh thirty Seven three eighty Two lakh fifty eight

8 Dr. Lalwani GlaxoSmithKline Pharmaceuticals Ltd Dr. Lalwani Sanofi Pasture Shrirang Godbole ICMR Aditya lal ICMR (MMR) vaccine (Live) (Freezedried) of M/s Cadila ealthcare Ltd. in healthy pediatric subjects aged -18 months FLU D QIV- A phase III, observerblind, randomized, multi-country, non-influenza vaccine comparator-controlled study to demonstrate the efficacy of GlaxoSmithKline Biological quadrivalent seasonal influenza candidate vaccine GSK23218A (FLU D-QIV), administered intramuscularly in children 6 to 35 months of age exaxim - Immunogenicity and Safety of Sanofi Pasteur s DTaP- IPV-ep B-PRP-T Combined Vaccine Given at 6, 10 and 14 Weeks of Age in Infants from India Who Previously Received a Dose of epatitis B Vaccine at Birth. (A3L33) Screening for dementia in the elderly. Effect of cigarette smoking on audio-visual reaction time in students pursuing professional course lakh Fifty three four eight one Twenty two lakh Fifty nine two eighty eight

9 Raghavi Bembey ICMR Tanmay Vaidya ICMR Prutha Dandawate ICMR Peeyush Belsare ICMR Poonam Patil ICMR Robin Raju ICMR Mohsin Murshid ICMR Nikita Sane ICMR Siddharth ardikar ICMR Effect of sleep deprivation on cognitive functions and cardiovascular parameters Study of road traffic accident cases in comparison with other emergency cases in the causality Comparison of Cefazolin-1 st gen. cephalosporin and ceftriaxone-3 rd gen cephalosporin for surgical prophylaxis Effect of drugs modulating serotonergic system on the antinociceptive action of Paracetamol in mice Comparison of non-exercise test and step test in estimation of aerobic capacity (VO2 max) in young adults Anthropometric measurement and assessment of physical activity questionnaire in young adults Association of serum ferritin levels with metabolic syndrome and insulin resistance Inter relation between glycemic status and bone profile in type 2 diabetes mellitus Comparative efficacy of topical Insulin, jatyadighrita and jatyadi

10 tail with silver sulphadiazinein diabetic wound healing in rats Pradnya Patkar ICMR Dr. Anuradha Joshi BVU Pune Dr. A.V. Phadke BVU Pune Dr. J.S. Kharche BVU Pune Correlation of Mechanism of Injuries with Clinical Findings in Cases of Road Traffic Accidents reporting to Bharati ospital, Pune Effect of examination stress on salivary cortisol levels in students pursuing professional course. Association of obesity with homocysteine levels in postmenopausal women Association of vitamin D and blood pressure in middle aged women Twenty

11 Dr.Mrs. Priti P. Dhande BVU Pune Dr Dawane J.S. BVU Pune Dr. Sanjay Lalwani WO funded Evaluation of effect of Jatyadi Ghrita in diabetic wound healing in rats Evaluation of anti-diabetic activity of Nishamlaki on streptozotocin induced type II diabetic rats WO Polio- Comparative evaluation of immunogenicity and reactogenicity of bivalent oral poliovirus vaccine (bopv) and trivalent oral poliovirus vaccine (topv) in the standard EPI schedule, with or without inactivated polio vaccine (IPV) 14/ / ,92,926 Thirty Nineteen Lakh Ninety two Nine twenty six

12 20-14 Dr Smita Nilegaonkar BVU Pune administration at DTP3 contact: A randomized controlled trial Studies on effect of Prebiotic and resistant starch enriched food preparations in healthy subjectsa preliminary study Dr A G Diwan RSSDI RAGE in Type II Diabetes Mellitus Dr A G Diwan RSSDI Dr A G Diwan DBT Serum Vitamin D level in Type II Diabetes Mellitus Studies on Glycation induced modifications in Diabetes RSSDI /Q/ Grant s 20 /96 RSSDI /Q/ Grant s 2014 /64 BT/Bi o- Care/ / /28/ 20 5/7/ /21/ 20 3,50, Three lakh fifty Seven lakh fifty Seventy five Seven lakh twenty five two fourty nine

13 Dr. A. Pranita BVU Pune Dr. Mrunal Ketkar BVU Pune Dr. Mrunal Ketkar BVU Pune Metabolic syndrome biomarkers and nutritional status in young adults Studying the expression of molecular markers in normal, benign and cancerous breast tissues of breast cancer patients Assessing the effect of herbal medicines on cell lines developed from breast tissue of patients suffering from breast cancer Thirty Thirty

Prospective Models of Vaccine Security Collaborations in Research and Development

Prospective Models of Vaccine Security Collaborations in Research and Development Prospective Models of Vaccine Security Collaborations in Research and Development Georges Thiry, PhD IVI (International Vaccine Institute) Phuket, Oct 01, 2014 Content R&D Examples of collaborations from

More information

Pranita postmenopausal women

Pranita postmenopausal women Sr. Name of no. dept 1 Communit Major/Mi nor Project Major (> External funding agenc /BVU Bill and Melinda Gates Foundation and INCLEN trust Research projects, Newl Implemented- 2015-16 Title of project

More information

Birth 6 wk 10 wk 14 wk 18 wk 6 mo 9 mo 12 mo 15 mo 18 mo mo 2-3 Yr 4-6 Yr 7-10Yr Yr 13-18Yr

Birth 6 wk 10 wk 14 wk 18 wk 6 mo 9 mo 12 mo 15 mo 18 mo mo 2-3 Yr 4-6 Yr 7-10Yr Yr 13-18Yr Vaccine BCG Age Birth 6 wk 10 wk 14 wk 18 wk 6 mo 9 mo 12 mo 15 mo 18 mo 19-23 mo 2-3 Yr 4-6 Yr 7-10Yr 11-12 Yr 13-18Yr BCG Hep B Hep B1 Hep B2 Hep B3 Polio OPV 0 IPV1 IPV2 IPV3 OPV1 OPV2 IPV B1 OPV3 DTP

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Bhutan 2017 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles containing

More information

Experience with the first wp based fully liquid hexavalent vaccine.

Experience with the first wp based fully liquid hexavalent vaccine. Experience with the first wp based fully liquid hexavalent vaccine. EasySix TM Vaccine R K Suri Senior Advisor & Former Chief Executive- Biologicals Panacea Biotec Ltd New Delhi, INDIA October 31, 2018

More information

CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES

CHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o

More information

VACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES

VACCINE MANAGEMENT. Recommendations for Handling and Storage of Selected Biologicals. January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES VACCINE MANAGEMENT Recommendations for Handling and Storage of Selected Biologicals January 2001 DEPARTMENT OF HEALTH AND HUMAN SERVICES DTaP: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine

More information

Deployment of Combination Vaccines and STI vaccines

Deployment of Combination Vaccines and STI vaccines Deployment of Combination Vaccines and STI vaccines Advancing Prevention Technologies for Sexual and Reproductive Health Symposium Berkeley, Ca March 24, 2009 Eileen Yamada, MD, MPH California Department

More information

Department of Pediatrics : Research projects

Department of Pediatrics : Research projects Year Project Funder 1980-86 Copper & ICC Wellcome Trust, UK 1985 onwards Wilson s Disease Rotary Rowikem Liver and gastroenterology 1995-1997 Genetics of Wilson s Disease 1995-1998 Pediatric endoscopies

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Sri Lanka 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04.

Public Statement: Medical Policy. Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many. Document: ARB0454:04. ARBenefits Approval: 01/01/2012 Effective Date: 01/01/2012 Revision Date: 03/24/2014 Code(s): Many Medical Policy Title: Immunization Coverage Document: ARB0454:04 Administered by: Public Statement: 1.

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Timor-Leste 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Expanded Programme on Immunization (EPI)

Expanded Programme on Immunization (EPI) Indonesia 217 Expanded Programme on Immunization (EPI) FACT SHEET Acronyms AD Auto disable MCV1 First dose measles containing vaccine AEFI Adverse events following immunization MCV2 Second dose measles

More information

Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age)

Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Detailed cost of vaccination/ Immunization in India (Birth to 10 years of age) Glossary: IPV= Injectable Polio vaccine OPV= Oral polio vaccine (these are oral drops, which is also given in "Pulse Polio

More information

Programme update. Prequalification of Vaccines

Programme update. Prequalification of Vaccines Programme update Prequalification of Vaccines UN Prequalification of Medicines, Diagnostics and Vaccines 6th Consultative Stakeholder Meeting 4 April 2011 David Wood, WHO/IVB/QSS Outline Good news - A

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sat, 17 Nov 2018 14:20:06 GMT) CTRI Number Last Modified On 10/05/2016 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

These slides are the property of the presenter. Do not duplicate without express written consent.

These slides are the property of the presenter. Do not duplicate without express written consent. Cancer Survivorship Protecting Against Vaccine Preventable Diseases Heidi Loynes BSN, RN Immunization Nurse Educator Michigan Department of health and Human Services (MDHHS) loynesh@michigan.gov Are Vaccine-Preventable

More information

New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines

New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines New Jersey Department of Health Vaccine Preventable Disease Program Childhood and Adolescent Recommended Vaccines Antigens Vaccine Approved Age Daptacel Diphtheria, Tetanus, and acellular Pertussis (DTaP)

More information

ROTAVIRUS VACCINES. Virology

ROTAVIRUS VACCINES. Virology ROTAVIRUS VACCINES Virology Rotavirus is a triple-layers viral particle belonging to the Reoviridae family. It contains 11 segments of double-stranded RNA, of which 6 are structural and 5 are non-structural

More information

Immunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012

Immunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012 Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants

More information

Phase 3 efficacy study of a new pentavalent bovine-human reassortant rotavirus vaccine in India

Phase 3 efficacy study of a new pentavalent bovine-human reassortant rotavirus vaccine in India Phase 3 efficacy study of a new pentavalent bovine-human reassortant rotavirus vaccine in India 12 th International Rotavirus Symposium 7-9 September 2016, Melbourne Dr Prasad Kulkarni, MD Serum Institute

More information

Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines

Table Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND

More information

VACCINE DIALOGUE AIDC 2017

VACCINE DIALOGUE AIDC 2017 VACCINE DIALOGUE AIDC 2017 Idea is Not to discuss about each vaccine Discuss about when to use- clinical situations Allaying the fears ADULT VACCINES Question What are the current CDC recommendations on

More information

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712.

Table 1: Basic information ,000, (per 1,000 LB) 34.6 (per 1,000 LB) 174 (per 100,000 LB) District 712. EPI history EPI launched in 978 with DPT, OPV, BCG and typhoid vaccines TT immunization of pregnant women introduced in 983 MCV introduced in 985 HepB piloted in 00 and made universal in 0 MCV introduced

More information

DCVMN AND VACCINE SECURITY IN ASEAN REGION. ASEAN Countries on Opportunities for Regional Vaccine Security 1-3 October, 2014.

DCVMN AND VACCINE SECURITY IN ASEAN REGION. ASEAN Countries on Opportunities for Regional Vaccine Security 1-3 October, 2014. DCVMN AND VACCINE SECURITY IN ASEAN REGION ASEAN Countries on Opportunities for Regional Vaccine Security 1-3 October, 2014. Phuket - Thailand Developing Countries Vaccine Manufacturers Network (DCVMN)

More information

FIMDP 2013 DEPT OF COMMUNITY MEDICINE SRM MEDICAL COLLEGE,SRM UNIVERSITY & UNSW AUSTRALIA 9 TH & 10 TH JAN 2013

FIMDP 2013 DEPT OF COMMUNITY MEDICINE SRM MEDICAL COLLEGE,SRM UNIVERSITY & UNSW AUSTRALIA 9 TH & 10 TH JAN 2013 FIMDP 2013 DEPT OF COMMUNITY MEDICINE SRM MEDICAL COLLEGE,SRM UNIVERSITY & UNSW AUSTRALIA 9 TH & 10 TH JAN 2013 Immunization Dr A Prema Prof. & HOD, Dept of Pediatrics SRM Medical College Beginning of

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Sun, 06 Jan 2019 11:39:39 GMT) CTRI Number Last Modified On 15/02/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

GENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES

GENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES GENERAL IMMUNIZATION GUIDE FOR CHILDCARE PROVIDERS August 2018 **CHILD VACCINES** DIPHTHERIA, TETANUS, PERTUSSIS VACCINES DTaP: Diphtheria, Tetanus, acellular Pertussis Vaccine Infanrix Licensed in 1997

More information

New and Underused Vaccines, Rotavirus

New and Underused Vaccines, Rotavirus New and Underused Vaccines, Rotavirus George Armah Noguchi Memorial Institute for Medical research University of Ghana 10th Annual African Vaccinology Course (VACFA) Cape town, South Africa 10 th to 14

More information

Immunizations are among the most cost effective and widely used public health interventions.

Immunizations are among the most cost effective and widely used public health interventions. Focused Issue of This Month Recommended by the Korean Pediatric Society, 2008 Hoan Jong Lee, MD Department of Pediatrics, Seoul National University College of Medicine E mail : hoanlee@snu.ac.kr J Korean

More information

Vaccines, Not Just for Babies

Vaccines, Not Just for Babies Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in

More information

Benefit Interpretation

Benefit Interpretation Benefit Interpretation Subject: Part B vs. Part D Vaccines Issue Number: BI-039 Applies to: Medicare Advantage Effective Date: May 1, 2017 Attachments: Part B Vaccines Diagnosis Code Limits Table of Contents

More information

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG)

Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Addendum to IPV Introduction Guidelines based on Recommendations of India Expert Advisory Group (IEAG) Background India was certified polio-free along with 10 other countries of WHO South-East Asia Region

More information

CPT 2016 Code Changes

CPT 2016 Code Changes CPT 2016 Code Changes Code Changes - Medicine New CPT 2016 New Codes Code Description 69209 Removal impacted cerumen using irrigation/lavage, unilateral 90620 Meningococcal recombinant protein and outer

More information

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply. An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation

More information

UNICEF Safe Injection Equipment Key highlights

UNICEF Safe Injection Equipment Key highlights Safe Injection Equipment VPPEF 03 October 2017 UNICEF Safe Injection Equipment Key highlights Nagwa Hasanin, HTC Vaccine Pharmaceutical form Route of administration Liquid Freeze- dried oral Inject Site

More information

Bharat Biotech. Hyderabad. Type of PAC (Supplement and Notifiable / Permission Granted by CDSCO) S. No Product

Bharat Biotech. Hyderabad. Type of PAC (Supplement and Notifiable / Permission Granted by CDSCO) S. No Product Bharat Biotech Hyderabad S. No Product Type of PAC (Supplement and / Permission Granted by CDSCO) PAC Details Date of NOC in manufacturing process of Oral Polio F.No. 12-63/BHARAT/(PACOPV)/13-BD 30.08.2013

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Thu, 17 Jan 2019 04:33:43 GMT) CTRI Number Last Modified On 26/06/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Pentabio Vaccine (DTP-HB-Hib)

Pentabio Vaccine (DTP-HB-Hib) SUMMARY OF PRODUCT CHARACTERISTICS Product Name Pharmaceutical Form Strength Presentation : Pentabio : Suspension for injection : 1, 5 and 10 doses : Box of 10 vials @ 0.5 ml Box of 10 vials @ 2.5 ml Box

More information

Pertussis. (Whole-cell pertussis vaccines) must not be frozen, but stored at 2 8 C. All wp vaccines have an expiry date of months.

Pertussis. (Whole-cell pertussis vaccines) must not be frozen, but stored at 2 8 C. All wp vaccines have an expiry date of months. Program Management 61_5 The wp vaccines have a considerably lower price than ap vaccines and, where resources are limited and the vaccine is well accepted by the local population, wp vaccine remains the

More information

1 Principles of Vaccination Immunology and Vaccine-Preventable Diseases... 1 Classification of Vaccines... 4 Selected References...

1 Principles of Vaccination Immunology and Vaccine-Preventable Diseases... 1 Classification of Vaccines... 4 Selected References... 1 Principles of Vaccination Immunology and Vaccine-Preventable Diseases... 1 Classification of Vaccines... 4 Selected References... 7 2 General Recommendations on Immunization Timing and Spacing of Vaccines...

More information

Table 1: Basic information 2017

Table 1: Basic information 2017 EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB

More information

Immunization Guidelines For the Use of State Supplied Vaccine July 1, 2011

Immunization Guidelines For the Use of State Supplied Vaccine July 1, 2011 DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,

More information

CHILDHOOD VACCINATION

CHILDHOOD VACCINATION EPI (3) Age of Child How and Where is it given? CHILDHOOD VACCINATION Nicolette du Plessis Block 10 28/02/2012 10 weeks DTaP-IPV/Hib (2) Diphtheria, Tetanus, Acellular pertussis, Inactivated polio vaccine,

More information

Immunization Guidelines for the Use of State Supplied Vaccine April 18, 2013

Immunization Guidelines for the Use of State Supplied Vaccine April 18, 2013 DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,

More information

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply.

PREVENTIVE IMMUNIZATIONS. PREVENTIVE IMMUNIZATIONS These codes do not have a diagnosis code requirement for preventive benefits to apply. An immunization that does not fall under one of the exclusions in the Certificate of Coverage is considered covered after the following conditions are satisfied: (1) FDA approval; (2) explicit ACIP recommendation

More information

Status of SII Bovine Rotavirus Pentavalent Vaccine (BRV-PV)

Status of SII Bovine Rotavirus Pentavalent Vaccine (BRV-PV) Status of SII Bovine Rotavirus Pentavalent Vaccine (BRV-PV) Dr Prasad Kulkarni, MD Serum Institute of India Limited Pune Rotavirus symposium, 03 September 2014, New Delhi 03 September 2014 1 Origins of

More information

MODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE

MODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE MODEL INSERT MEASLES, MUMPS AND RUBELLA (MMR) COMBINED VACCINE DESCRIPTION The vaccine is a freeze-dried powder containing three viruses - measles, mumps and rubella. a) The measles vaccine component is

More information

Calender of Pediatric Immunizations in Brazil

Calender of Pediatric Immunizations in Brazil Calender of Pediatric Immunizations in Brazil Otávio Augusto Leite Cintra 1. Background Immunization or vaccination is one of the more effective actions for disease prevention in the individual and community

More information

The administration of covered immunizations and vaccines also is covered.

The administration of covered immunizations and vaccines also is covered. Covered Benefit: Immunization & Vaccines Definitions: CMP Published: Yes No CMP Link: CPG Link: Pediatric, Adolescent and Adult Routine Preventative Services Immunizations and vaccinations for treatment

More information

Alternative Rotavirus Vaccine Candidates: Why should we bother?

Alternative Rotavirus Vaccine Candidates: Why should we bother? Alternative Rotavirus Vaccine Candidates: Why should we bother? Duncan Steele Initiative for Vaccine Research, WHO 7 th International Rotavirus Symposium 12-13 June 2006, Lisboa, Portugal Rotavirus Vaccines

More information

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB)

Table 1: Basic information (per 1,000 LB) 42.4 (per 1,000 LB) 49.7 (per 1,000 LB) 215 (per 100,000 LB) EPI history EPI started in 978 EPI re-structured in March 000 DTP-HepB vaccine introduced in 007 DTP-Hib-HepB)vaccine introduced in 0 MR vaccine introduced in Feb 06 Second dose of MR introduced in Feb

More information

PDF of Trial CTRI Website URL -

PDF of Trial CTRI Website URL - Clinical Trial Details (PDF Generation Date :- Thu, 18 Oct 2018 14:39:26 GMT) CTRI Number Last Modified On 06/04/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study

More information

Advisory Committee on Immunization Practices VACCINE ACRONYMS

Advisory Committee on Immunization Practices VACCINE ACRONYMS Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table of standardized

More information

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000

Total population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000 India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written

More information

Child Health and Disability Prevention (CHDP) Program Code Conversion

Child Health and Disability Prevention (CHDP) Program Code Conversion Child Health and Disability Prevention (CHDP) Program Code Conversion Health s All s are effective for dates of service on or after July 1, 2017. (Select s for laboratory-only providers with effective

More information

Advisory Committee on Immunization Practices VACCINE ACRONYMS

Advisory Committee on Immunization Practices VACCINE ACRONYMS May 1, 2015 Vaccine Acronyms Page 1 of 5 Advisy Committee on Immunization Practices VACCINE ACRONYMS Vaccines Included in the Immunization Schedules f Children, Adolescents, and Adults Following is a table

More information

How and Why Vaccines Are Developed by Industry. Stanley A. Plotkin

How and Why Vaccines Are Developed by Industry. Stanley A. Plotkin How and Why Vaccines Are Developed by Industry Stanley A. Plotkin Merieux 2012 1 Why Vaccines are Different than Drugs 1) Given to healthy people, high safety required 2) Larger governmental role 3) Low

More information

ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT

ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT RotaTeq Solution for Oral Administration THERAPEUTIC CLASS ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT hereafter referred to as PENTAVALENT ROTAVIRUS VACCINE (RotaTeq),

More information

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100

Total population 20,675,000. Live births (LB) 349,715. Children <1 year 346,253. Children <5 years 1,778,050. Children <15 years 5,210,100 Sri Lanka 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization system strengthening covering -6. A national policy on immunization has been developed. A standing

More information

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine

VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper

More information

Hexavalent Vaccines: Hepatitis B antibody response and co-administration with other vaccines

Hexavalent Vaccines: Hepatitis B antibody response and co-administration with other vaccines Viral Hepatitis Prevention Board Hanoi, 25 26 July 2018 Hexavalent Vaccines: Hepatitis B antibody response and co-administration with other vaccines Prof. Timo Vesikari Vaccine Research Center University

More information

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210 EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Routine Immunizations Table of Contents Coverage Policy... 1 General Background... 2 Coding/Billing Information... 3 References... 7 Effective Date... 4/15/2018

More information

Development of a heat-stable Rotavirus vaccine using innovative delivery technology

Development of a heat-stable Rotavirus vaccine using innovative delivery technology Development of a heat-stable Rotavirus vaccine using innovative delivery technology 1 HILLEMAN OPERATING MODEL IS UNIQUE WITH FOCUS ON TRANSLATIONAL SCIENCE AND GETTING AFFORDABLE VACCINES TO MARKET FASTER

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT IP Solution for Oral Administration 2 ml single dose plastic dosing tube Brand Name: RotaTeq SUMMARY OF PRODUCT CHARACTERISTICS

More information

Summary of product characteristics As per Annexure C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1

Summary of product characteristics As per Annexure C. SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1 Summary of product characteristics As per Annexure C SUMMARY OF PRODUCT CHARACTERISTICS Doc. No. SPC/71108 Ver.1 1. NAME OF THE MEDICINAL PRODUCT. ANNEXURE C to MODULE I Measles, Mumps & Rubella Vaccine

More information

The supply landscape and economics of IPV-containing combination vaccines: Key findings

The supply landscape and economics of IPV-containing combination vaccines: Key findings The supply landscape and economics of IPV-containing combination vaccines: Key findings Commissioned by the Bill & Melinda Gates Foundation Prepared by Oliver Wyman, www.oliverwyman.com May 2010 Project

More information

Interrupted primary series***

Interrupted primary series*** (Updated March 2017) Table 3: Recommendations* for Interrupted or Delayed Routine Immunization - Summary of WHO Position Papers Antigen Age of 1st Dose Doses in Primary Series (min interval between s)**

More information

Lester A. Deniega M.D. Associate Professor Department of Pediatrics FPPS, FPIDSP

Lester A. Deniega M.D. Associate Professor Department of Pediatrics FPPS, FPIDSP Highlights in Pediatric Infectious Diseases Lester A. Deniega M.D. Associate Professor UST Department of Pediatrics FPPS, FPIDSP The 29 Antimic crobial Resistance Surveillance Pro ogram Progress Rep port

More information

The administration of covered immunizations and vaccines also is covered.

The administration of covered immunizations and vaccines also is covered. Covered Benefit: Vaccines & Immunization Definitions: CMP Published: Yes No CMP Link: CPG Link: Pediatric, Adolescent and Adult Routine Preventative Services Immunizations and vaccinations for treatment

More information

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010

Polio vaccines and polio immunization in the pre-eradication era: WHO position paper. Published in WER 4 June, 2010 Polio vaccines and polio immunization in the pre-eradication era: WHO position paper Published in WER 4 June, 2010 Epidemiology & Background Poliomyelitis (polio) is an acute communicable disease of humans

More information

COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP

COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP 34 Buletin Kesihatan Masyarakat Isu Khas 2000 COMBINATION VACCINE - THE IMPORTANCE AND ROLE IN PUBLIC HEALTH SET UP Rahman. I.* ABSTRACT Infectious diseases are the world's leading cause of death. Vaccines

More information

Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study

Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study Simplifying pediatric immunization with a fully liquid pentavalent vaccine: Evidence from a time-motion study Dr. Karin Anne Wiedenmayer Swiss Tropical Institute Basel, Switzerland February 2008 1 Value

More information

Developing a novel Group B Streptococcus (GBS) Vaccine. Patrick Tippoo

Developing a novel Group B Streptococcus (GBS) Vaccine. Patrick Tippoo Developing a novel Group B Streptococcus (GBS) Vaccine Patrick Tippoo Presentation 1. Overview of Biovac 2. GBS Project Overview 3. African Significance Biovac Overview A Centre of Excellence rooted in

More information

Preventive Care Services

Preventive Care Services Preventive Care Services Preventive Care Services What are preventive care services? It s important to visit your doctor regularly to get preventive care. Preventive care lets your doctor find potential

More information

The Science of Vaccines:

The Science of Vaccines: The Science of Vaccines: Addressing Common Concerns Paul A. Offit Division of Infectious Diseases Children s Hospital of Philadelphia Perelman School of Medicine The University of Pennsylvania Are vaccines

More information

Updates on Rotasiil development

Updates on Rotasiil development Updates on Rotasiil development 13 th International Rotavirus Symposium Minsk, Belarus 30 August 2018 Dr Sajjad Desai MD Serum Institute of India Pvt Limited, Pune Rotasiil Bovine-human reassortant strains

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Poliomyelitis Vaccine, Live (Oral) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.1 ml = 2 drops contains: Polio Virus Type 1 (Sabin strain) Not less than 10

More information

Immunization Guidelines for the Use of State Supplied Vaccine May 17, 2015

Immunization Guidelines for the Use of State Supplied Vaccine May 17, 2015 DTaP / DT DTaP/IPV/Hep B Combination (Pediarix ) Children from 6 weeks of age up to the 7 th birthday Children from 2 months of age up to the 7th birthday: Indicated for the primary doses of DTaP, IPV,

More information

GAVI Role in IPV Introductions

GAVI Role in IPV Introductions GAVI Role in IPV Introductions Melissa Malhame 12 th WHO/UNICEF Consultation with OPV/IPV Manufacturers and National Regulatory Authorities Geneva, Switzerland, 10 GAVI vaccine support Currently supported

More information

Recruitment barriers associated to prophylactic vaccine trials in Belgium. Lauriane Harrington GSK. Secondee at the Vaccines Centre of Excellence

Recruitment barriers associated to prophylactic vaccine trials in Belgium. Lauriane Harrington GSK. Secondee at the Vaccines Centre of Excellence Recruitment barriers associated to prophylactic vaccine trials in Belgium Lauriane Harrington GSK. Secondee at the Vaccines Centre of Excellence Disclosure Employee of GSK Biologicals, Belgium Secondment

More information

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287 Program Management 82_19 SAGE encouraged all countries to consider their preparedness for a potential influenza pandemic, recognizing that it would occur before strain-specific vaccine can be made in significant

More information

Vaccine Label Examples

Vaccine Label Examples Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can

More information

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093

Total population 24,759,000. Live births (LB) 342,458. Children <1 year 337,950. Children <5 years 1,698,664. Children <15 years 5,233,093 DPR Korea 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering -5. A standing national technical advisory group on immunization (NTAGI) with formal

More information

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Pneumococcal vaccination in UK: an update Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Leading infectious causes of mortality, 2000 WHO estimates 3.5 Deaths

More information

Study No.: Title: Rationale: Note: Phase: Study Period: Study Design: Centres: Indication: Treatment: Hib-MenCY F1 Group Hib-MenCY F2 Group

Study No.: Title: Rationale: Note: Phase: Study Period: Study Design: Centres: Indication: Treatment: Hib-MenCY F1 Group Hib-MenCY F2 Group The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.

More information

A Review of Pediatric Vaccines Gary Overturf, M.D. Professor of Pediatrics, Inf. Dis. University of New Mexico

A Review of Pediatric Vaccines Gary Overturf, M.D. Professor of Pediatrics, Inf. Dis. University of New Mexico Review of Pediatric and Adolescent Vaccines 2012 Idaho Society of Health- System Pharmacists Boise, ID April 28 th 2012 A Review of Pediatric Vaccines - 2012 Gary Overturf, M.D. Professor of Pediatrics,

More information

Vaccines Prevent Illness

Vaccines Prevent Illness Vaccines Prevent Illness Vaccinations, also called immunizations, can prevent many illnesses that might otherwise make people sick or even cause death. Vaccines work by strengthening the body s immune

More information

07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc.

07/20/17, 05/17/18 CATEGORY: Vaccines/Biologics. Proprietary Information of Excellus Health Plan, Inc. MEDICAL POLICY SUBJECT: IMMUNIZATIONS PAGE: 1 OF: 9 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product (including an Essential

More information

Copyright regulations Warning

Copyright regulations Warning COMMONWEALTH OF AUSTRALIA Copyright regulations 1969 Warning This material has been reproduced and communicated to you by or on behalf of the University of Melbourne pursuant to part VB of the Copyright

More information

New Vaccines in SA. Regulatory Perspectives James Southern 2015

New Vaccines in SA. Regulatory Perspectives James Southern 2015 New Vaccines in SA Regulatory Perspectives James Southern 2015 Outline Regulatory Environment of new vaccines Clinical Trials Application procedures HIV Vaccines Other new vaccines in development Ongoing

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Synflorix suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (adsorbed) 2. QUALITATIVE

More information

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS Ranjana Kumar International Rotavirus Symposium Istanbul, 3 4 June 2008 The GAVI Alliance Public-private partnership bringing

More information

Line Diagnosis 2017 Codes 2018 Codes. 3 Tuberculosis A15- through A19- A15- through A19-, O98.01-

Line Diagnosis 2017 Codes 2018 Codes. 3 Tuberculosis A15- through A19- A15- through A19-, O98.01- Table 6A Code Changes Table 6A: Selected Diagnoses and Services Rendered * Indicates change from 2017 1-2. Selected Infectious and Parasitic Diseases Symptomatic / Asymptomatic HIV B20, B97.35, O98.7-,

More information

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central

Recommended Childhood Immunization Schedu...ates, January - December 2000, NP Central Recommended Childhood Immunization Schedule United States, January - December 2000 Vaccines 1 are listed under routinely recommended ages. Solid-colored bars indicate range of recommended ages for immunization.

More information

The reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents.

The reassortants are propagated in Vero cells using standard tissue culture techniques in the absence of antifungal agents. PRODUCT INFORMATION RotaTeq (rotavirus vaccine, live, oral, pentavalent, MSD) NAME OF THE MEDICINE Rotavirus vaccine live oral pentavalent DESCRIPTION RotaTeq is a live, oral pentavalent reassortant vaccine

More information

Vaccines: Poised To Deliver Significant Growth in Emerging Markets

Vaccines: Poised To Deliver Significant Growth in Emerging Markets Vaccines: Poised To Deliver Significant Growth in Emerging Markets 4 th DVFA Symposium Life Science Pierre Morgon Vice-President, Franchise & Global Marketing Operations, Sanofi Pasteur Frankfurt, May

More information

Vaccination schedules in Denmark

Vaccination schedules in Denmark Vaccination schedules in Denmark Tyra Grove Krause MD, PhD, Senior consultant Head of Dept. Of Infectious Disease Epidemiology and Prevention Statens Serum Institut e-mail: tgv@ssi.dk Agenda History of

More information